Exelixis News

Exelixis Analyst Ratings

Benzinga01:34

Exelixis Is Maintained at Market Outperform by JMP Securities

Dow Jones00:49

Stephens & Co. Reiterates Equal-Weight on Exelixis, Maintains $29 Price Target

BenzingaJan 27 22:36

Morgan Stanley Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $40

Futu NewsJan 27 21:34

Truist Financial Maintains Exelixis(EXEL.US) With Buy Rating, Announces Target Price $43

Futu NewsJan 27 21:34

Exelixis Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow JonesJan 27 21:04

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $34 to $43

Futu NewsJan 27 21:00

Stifel Nicolaus Sticks to Their Hold Rating for Exelixis (EXEL)

TipRanksJan 27 20:57

Exelixis (EXEL) Gets a Buy From TD Cowen

TipRanksJan 27 20:35

Analysts Are Bullish on Top Healthcare Stocks: Scilex Holding Company (SCLX), Exelixis (EXEL)

TipRanksJan 27 20:35

Exelixis: Hold Rating Maintained Amidst Comparable Efficacy and Risks of Zanza and Cabo

TipRanksJan 27 19:57

Exelixis Raised to Overweight From Equal-Weight by Morgan Stanley

Dow JonesJan 27 18:21

Exelixis's Strategic Advancements in MCRC Market Capture Analyst's Buy Rating

TipRanksJan 27 13:48

Citi Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $38

Futu NewsJan 26 06:32

Exelixis Cut to Perform From Outperform by Oppenheimer

Dow JonesJan 24 20:31

Oppenheimer Downgrades Exelixis(EXEL.US) to Hold Rating, Cuts Target Price to $33

Futu NewsJan 24 06:31

JMP Securities Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $41

Futu NewsJan 23 14:32

Jefferies Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $42

Futu NewsJan 23 02:32

Promising Outlook for Exelixis's Zanza: Strong Trial Results and Financial Prospects Support Buy Rating

TipRanksJan 23 01:57

Exelixis Analyst Ratings

BenzingaJan 22 23:47